Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Acute Myeloid Leukemia(AML)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07366801
What this trial is testing

Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia, RelapsedAcute Lymphoblastic Leukemia, High RiskAcute Myeloid Leukemia, High Risk+1 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 64
Early research (Phase 1)Study completedNCT02038777
What this trial is testing

PF-04449913 In Japanese Patients With Select Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia
Pfizer 48
Early research (Phase 1)Ended earlyNCT05961839
What this trial is testing

Study of SGR-2921 in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaHigh-Risk and Very High-Risk Myelodysplastic Syndromes
Schrödinger, Inc. 66
Testing effectiveness (Phase 2)Ended earlyNCT02392572
What this trial is testing

ONC201 in Treating Patients With Relapsed or Refractory Acute Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
Recurrent Acute Lymphoblastic LeukemiaRecurrent Acute Myeloid LeukemiaRecurrent Myelodysplastic Syndrome+3 more
M.D. Anderson Cancer Center 58
Testing effectiveness (Phase 2)Ended earlyNCT00052598
What this trial is testing

Therapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+12 more
Fred Hutchinson Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT00049504
What this trial is testing

Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+94 more
Fred Hutchinson Cancer Center 53
Testing effectiveness (Phase 2)Study completedNCT01823198
What this trial is testing

Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Erythroid LeukemiaAcute Megakaryoblastic Leukemia+12 more
M.D. Anderson Cancer Center 63
Testing effectiveness (Phase 2)Study completedNCT00707408
What this trial is testing

High-Dose Imatinib for Relapsed/Refractory c-Kit Positive Acute Myelogenous Leukemia (AML)

Who this might be right for
AML
Nantes University Hospital 15
Not applicableActive Not RecruitingNCT05428176
What this trial is testing

A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors

Who this might be right for
Acute LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+1 more
City of Hope Medical Center 332
Testing effectiveness (Phase 2)Looking for participantsNCT05735717
What this trial is testing

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Who this might be right for
Hematologic MalignancyAcute LeukemiaRemission+21 more
Masonic Cancer Center, University of Minnesota 70
Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Testing effectiveness (Phase 2)Ended earlyNCT03301597
What this trial is testing

NLA101 in Adults Receiving High Dose Chemotherapy for AML

Who this might be right for
Leukemia, Myeloid, Acute
Nohla Therapeutics, Inc. 146
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06987058
What this trial is testing

RVU120 Rollover Study

Who this might be right for
Advanced Solid TumorsAcute Myeloid Leukaemia (AML)High-risk Myelodysplastic Syndrome
Ryvu Therapeutics SA 14
Testing effectiveness (Phase 2)Ended earlyNCT04914676
What this trial is testing

Accelerated Dose Schedule of Cytarabine Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML) in Complete Remission

Who this might be right for
Acute Myeloid Leukemia
University of Florida 5
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT00502905
What this trial is testing

Busulfan and Fludarabine in Patients With AML and MDS

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 200
Testing effectiveness (Phase 2)WithdrawnNCT00003405
What this trial is testing

Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia

Who this might be right for
Leukemia
Rush University Medical Center
Testing effectiveness (Phase 2)WithdrawnNCT05766514
What this trial is testing

Trial of Cladribine and Low-Dose Cytarabine (LoDAC) Alternating With Decitabine vs. Hypomethylating Agents (HMA) Plus Venetoclax as Frontline Therapy for AML or High-Grade MDS in Patients Unfit for Intensive Induction

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
University of Florida
Early research (Phase 1)Looking for participantsNCT05342584
What this trial is testing

Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Montefiore Medical Center 99
Testing effectiveness (Phase 2)Study completedNCT00691938
What this trial is testing

LBH589 Plus Decitabine for Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Washington University School of Medicine 52
Next Page